HCA Healthcare (NYSE:HCA) Shares Acquired Rep. Lisa C. McClain

Key Points

• Representative Lisa C. McClain has acquired shares of HCA Healthcare valued between $1,001 and $15,000, reflecting her recent investment activity in the healthcare sector.
• HCA Healthcare has recently reported a quarterly earnings per share (EPS) of $6.84, exceeding analysts' expectations and indicating a 6.4% revenue increase year-over-year.
• The company also announced a quarterly dividend of $0.72 per share, translating to an annualized dividend yield of 0.7%, with the payment date set for September 30th.

Representative Lisa C. McClain (R-Michigan) recently bought shares of HCA Healthcare, Inc. NYSE: HCA. In a filing disclosed on September 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in HCA Healthcare stock on August 19th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
• Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
• Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
• Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of AppFolio NASDAQ: APPF on 8/13/2025.

HCA Healthcare Trading Up 0.1%

HCA stock traded up $0.24 during trading on Tuesday, hitting $402.69. The company had a trading volume of 401,726 shares, compared to its average volume of 1,522,114. The stock has a market cap of $94.23 billion, a PE ratio of 16.94, a PEG ratio of 1.27 and a beta of 1.41. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $420.98. The business has a 50-day moving average of $383.38 and a 200-day moving average of $364.05.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter last year, the firm posted $5.50 EPS. The company's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's payout ratio is currently 12.11%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company's stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is owned by insiders.

Institutional Trading of HCA Healthcare

A number of hedge funds have recently modified their holdings of HCA. Norges Bank bought a new stake in HCA Healthcare during the second quarter worth about $1,152,408,000. GAMMA Investing LLC increased its holdings in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after acquiring an additional 1,699,713 shares in the last quarter. Nuveen LLC bought a new position in shares of HCA Healthcare in the first quarter worth approximately $569,217,000. Pacer Advisors Inc. raised its holdings in HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock worth $466,815,000 after acquiring an additional 1,329,618 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of HCA Healthcare by 83.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after buying an additional 1,091,416 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Morgan Stanley reduced their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday, July 28th. Bank of America upped their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday, September 10th. Finally, JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $403.17.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.